Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 607,400 | 575,100 | 522,400 | 536,000 | 495,600 |
| Cost of Goods | 168,100 | 151,200 | 145,900 | 143,800 | 128,200 |
| Gross Profit | 439,300 | 423,900 | 376,500 | 392,200 | 367,400 |
| Operating Expenses | 309,900 | 304,800 | 283,900 | 264,800 | 262,100 |
| Operating Income | 129,500 | 119,300 | 93,500 | 128,200 | 105,500 |
| Interest Expense | 2,500 | 3,100 | 3,500 | 8,600 | 1,000 |
| Other Income | -6,400 | 697,000 | -12,700 | -19,300 | -4,700 |
| Pre-tax Income | 120,600 | 813,200 | 77,300 | 100,300 | 99,800 |
| Income Tax | 26,000 | 266,200 | 17,000 | 25,200 | 23,000 |
| Net Income Continuous | 94,600 | 547,000 | 60,300 | 75,100 | 76,800 |
| Net Income | $94,600 | $547,000 | $60,300 | $75,100 | $76,800 |
| EPS Basic Total Ops | 0.15 | 0.86 | 0.10 | 0.12 | 0.12 |
| EPS Basic Continuous Ops | 0.15 | 0.86 | 0.09 | 0.12 | 0.12 |
| EPS Diluted Total Ops | 0.15 | 0.85 | 0.09 | 0.12 | 0.11 |
| EPS Diluted Continuous Ops | 0.15 | 0.85 | 0.09 | 0.12 | 0.11 |
| EBITDA(a) | $147,500 | $135,400 | $109,700 | $145,300 | $122,500 |